Susan E Yost

16PUBLICATIONS
77CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Dec 30, 2025
Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. Antioxidants 2025, 14, 345.

Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu

|Apr 14, 2025
The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate.

Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu

|Nov 29, 2023
CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study.

Yuan Yuan, Colt Egelston, Oscar Colunga Flores

|Jun 13, 2023
BRCA germline mutations in multiethnic gynecologic patients: A 10-year retrospective analysis from a single cancer institute.

Christina H Wei, Susan Shehayeb, Nicole Lugo Santiago

|Apr 06, 2023
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer.

Yuan Yuan, Susan E Yost, Yujie Cui

|Mar 11, 2023
Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer.

Dana Mahin, Sayeh Moazami Lavasani, Leon Cristobal

Pageof 3

Frequent Collaborators

4 joint publications

Joanne Mortimer

4 joint publications

Yuan Yuan

3 joint publications

Daniel Schmolze

2 joint publications

Hyejin Cho